Nationwide Fund Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Nationwide Fund Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-9,030	Closed	-$2.98M	–	3395
2014 Q1	$2.98M	Buy	9,030 +3,472	+62%	+$1.17M	0.01%	1131
2013 Q4	$380K	Sell	5,558 -147	-3%	-$8.49K	﹤0.01%	2363
2013 Q3	$394K	Buy	5,705 +1,656	+41%	+$81.8K	﹤0.01%	2343
2013 Q2	$182K	Buy	+4,049	New	+$138K	﹤0.01%	2530

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Nationwide Fund Advisors's ICPT Position: Q2 2014 in Review

Nationwide Fund Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2014, closing a stake of 9,030 shares — an estimated $2.98M sold.

Nationwide Fund Advisors first reported a position in ICPT in Q2 2013 and held it in 4 quarters. The position peaked at $2.98M in Q1 2014. 167 funds tracked by Wall St. Rank hold ICPT as of Q2 2014.

Nationwide Fund Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
Nationwide Fund Advisors sold 9,030 Intercept Pharmaceuticals, Inc. shares in Q2 2014, an estimated $2.98M.
Nationwide Fund Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
Nationwide Fund Advisors's Intercept Pharmaceuticals, Inc. position peaked at $2.98M in Q1 2014.
167 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2014.

Based on Nationwide Fund Advisors's 13F filing for Q2 2014, filed 11 Aug 2014.